Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.21.2
Consolidated Balance Sheets (Parentheticals) - USD ($)
Jun. 30, 2021
Jun. 30, 2020
Accounts receivable, net of allowance (in Dollars) $ 0 $ 0
Inventories, net of allowance (in Dollars) $ 24,403 $ 0
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, issued 80,707,467 61,796,680
Common stock, outstanding 80,707,467 61,796,680
Series A Stock    
Series Stock, par value (in Dollars per share) $ 0.001 $ 0.001
Series Stock, shares authorized 1,000,000 1,000,000
Series Stock, shares issued 1,000 1,000
Series Stock, shares outstanding 1,000 1,000
Series B Stock    
Series Stock, par value (in Dollars per share) $ 0.001 $ 0.001
Series Stock, shares authorized 5,000 5,000
Series Stock, shares issued 4,665 0
Series Stock, shares outstanding 4,665 0